Abstract:

While COVID-19 pandemic continues to spread worldwide, it is crucial that we develop appropriate clinical care policies to identify and protect risky populations. Although data on the incidence and consequences of the newborn SARS-CoV-2 infection continues to appear, there is more to learn. So far, evidence shows that vertical infection in the newborn is rare and that a greater percentage of infection is caught through postpartum respiratory drops or through contact with the infected mother or nurse. Most newborns do not develop symptoms associated with SARS-CoV-2, but prematurity-related morbidities may require intensive care and support. Regardless of the presence of symptoms, all newborns born from mothers suspected or confirmed of COVID-19 infection should be tested. Awareness of the condition of COVID-19 in newborns, prevention and control measures should be encouraged.

Keywords: